From: Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
Medications | Number (%) of subjects taking at baseline (N = 44) | Number of subjects lost to follow-up (N = 9) | Number (%) of subjects taking at endpoint (N = 35)a |
---|---|---|---|
High-potency conventional antipsychoticsb | 12 (27.3) | 2 | 4 (11.4) |
Medium-potency conventional antipsychoticsc | 4 (9.1) | 1 | 4 (11.4) |
Low-potency conventional antipsychoticsd | 5 (11.4) | 2 | 5 (14.3) |
Clozapine | 5 (11.4) | 2 | 7 (20.0) |
Olanzapine | 3 (6.8) | 1 | 5 (14.3) |
Risperidone | 14 (31.8) | 1 | 13 (37.1) |
Sertindole | 1 (2.3) | 0 | 12 (34.3) |